The Department of Science and Technology (DOST) disclosed on Friday, July 23, the completion of the country’s clinical trial on the efficacy and safety of convalescent plasma transfusion as adjunctive therapy to prevent disease progression among hospitalized coronavirus disease (COVID-19)...